Biotech CEO on House Dem's Rx Pricing Overhaul

H.R. 3 seeks to lower the wholesale costs of drugs while asking us to hope and pray that insurers will lower deductibles in response. They won't.



Comment
Show comments Hide Comments


Related Articles